CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY - USD ($) $ in Thousands	Total	At-The-Market Offering	PREFERRED STOCK	COMMON STOCK	COMMON STOCK At-The-Market Offering	ADDITIONAL PAID-IN CAPITAL	ADDITIONAL PAID-IN CAPITAL At-The-Market Offering	ACCUMULATED DEFICIT	ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)
Beginning balance (in shares) at Dec. 31, 2023			15,000
Beginning balance at Dec. 31, 2023			$ 0
Beginning balance (in shares) at Dec. 31, 2023				29,130,607
Beginning balance at Dec. 31, 2023	$ 21,291			$ 3		$ 418,487		$ (397,198)	$ (1)
Increase (Decrease) in Shareholders' Equity
Net Loss	(480)							(480)
Reclassification of Realized Gain on Available-for-Sale Investments	(25)								(25)
Unrealized Gain on Available-for-Sale Investments	85								85
Foreign Currency Translation Adjustments	(5)								(5)
Fair Value of Warrant Related to Debt Financing	247					247
Issuance of Common Stock, net of Issuance or Offering Costs / At-the-market offerings (in shares)					4,718,923
Issuance of Common Stock, net of Issuance or offering Costs / At-the-market offerings		$ 10,172					$ 10,172
Vesting of Restricted Stock Units Issued, net of taxes withheld (in shares)				201,348
Issuance of Common Stock Upon Exercise of Option (in shares)				6,042
Issuance of Common Stock Upon Exercise of Options	9					9
Stock-based Compensation	$ 1,292					1,292
Ending balance (in shares) at Dec. 31, 2024	15,000		15,000
Ending balance at Dec. 31, 2024	$ 0		$ 0
Ending balance (in shares) at Dec. 31, 2024	34,056,920			34,056,920
Ending balance at Dec. 31, 2024	$ 32,586			$ 3		430,207		(397,678)	54
Increase (Decrease) in Shareholders' Equity
Net Loss	(5,314)							(5,314)
Reclassification of Realized Gain on Available-for-Sale Investments	(267)								(267)
Unrealized Gain on Available-for-Sale Investments	344								344
Foreign Currency Translation Adjustments	0
Issuance of Common Stock, net of Issuance or Offering Costs / At-the-market offerings (in shares)					4,964,636
Issuance of Common Stock, net of Issuance or offering Costs / At-the-market offerings		$ 7,800		$ 1			$ 7,799
Vesting of Restricted Stock Units Issued, net of taxes withheld (in shares)				373,433
Issuance of Common Stock Upon Exercise of Option (in shares)				10,313
Issuance of Common Stock Upon Exercise of Options	16					16
Stock-based Compensation	$ 1,816					1,816
Ending balance (in shares) at Dec. 31, 2025	15,000		15,000
Ending balance at Dec. 31, 2025	$ 0		$ 0
Ending balance (in shares) at Dec. 31, 2025	39,405,302			39,405,302
Ending balance at Dec. 31, 2025	$ 36,981			$ 4		$ 439,838		$ (402,992)	$ 131